Biocon Share Price

Q: How to buy Biocon Share at Choice?

To buy Biocon stocks , log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Biocon, choose your preferred order type, and place the trade.

BIOCON

Healthcare Large Cap

35010.00 (-2.78%)

NSE

BSE

Last updated on 8 Oct, 2026 | 15:57 IST

BuySell

Today's High

361.15

Today's Low

347.20

52 Week Low

337.70

52 Week High

447.15

Free Demat with Zero AMC*

Summary

As of 9 Oct, 2026, Biocon stock price is ₹350. During the trading session, the stock has moved between an intraday low of ₹347.20 and an intraday high of ₹361.15. Over the last 52 weeks, Biocon has traded between ₹337.70 and ₹447.15.

The stock has recorded a trading volume of 21,35,284 shares,. Its Average Traded Price (ATP) is ₹351.38, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 24 @ ₹350.00.

Biocon has an upper circuit limit of ₹396.00 and a lower circuit limit of ₹324.00. The total value traded stands at ₹75.03 CR, and the delivery percentage for the day is 51.16%.

The stock is currently traded with a market lot size of 1. Biocon also offers a dividend yield of 0.14%.

Biocon Share Price Chart

ChartIQ

TradingView

Biocon Share Key Metrics

Volume

21.35 L

Market Cap

57039.29 CR

LTQ@LTP

24@350.00

ATP

351.38 Var Margin

14.48 %

Circuit Range

324-396

Delivery %

51.16 %

Value

75.03 CR

ASM/GSM

No

Market Lot

1

Biocon Fundamentals

P/E Ratio

118.62

P/B Ratio

1.73

Div. Yield

0.14

Sector P/E

42.71

Sector P/B

3.58

Sec. Div. Yield

0.52

Biocon Resistance and Support

Pivot 362.27

Resistance

First Resistance

366.14

Second Resistance

372.27

Third Resistance

376.14

Support

First Support

356.14

Second Support

352.27

Third Support

346.14

Biocon Futures & Options

Biocon Ltd Share Price

350 -10 (-2.78%)

Biocon Option Chain

View Price, OI, Greeks & More...

View All

27OCT26

349.00 -11.35 (3.15%)

23NOV26

351.35 -10.95 (3.02%)

29DEC26

352.95 -11.50 (3.16%)

BIOCON|27OCT26 CE 345.00

11.20 -66.5 (-85.59%)

BIOCON|27OCT26 PE 350.00

8.95 3.9 (77.23%)

Biocon Shareholding Pattern

2016-17
2018-19
2019-20
2020-21
2021-22
2022-23
2023-24
2024-25
2025-26
2026-27

Segment

Percent

Total Promoters

44.68%

Mutual Fund

15.47%

Insurance

6.37%

Foreign Institutional Investors

8.14%

Domestic Institutional Investors

1.54%

Retail

23.8%

Others

Total Promoters

MAR '26

44.91%

JUN '26

44.68%

Biocon Historical Data

Day	Open	Close	Change(%)	Day High	Day Low
Thu Oct 08 2026	360.5	350	-2.78%	361.15	347.2
Wed Oct 07 2026	368.39	360	-2.47%	368.39	358.39
Tue Oct 06 2026	369.7	369.1	-0.19%	371	366.6

Biocon Corporate Actions

Date	Agenda
2026-08-05	Quarterly Results
2026-05-07	Audited Results & Final Dividend
2026-02-12	Quarterly Results
2025-11-11	Quarterly Results
2025-10-01	Redemption (Part) of NCD
2025-08-07	Quarterly Results
2025-05-08	Audited Results & Final Dividend
2025-04-23	Others
2025-04-04	To consider Fund Raising
2025-01-30	Quarterly Results & Others
2025-01-27	Others
2024-10-30	Quarterly Results

Ex Date	Record Date
2026-07-03	2026-07-03	View More

Biocon News

Biocon Ltd - 532523 - Company Secretary

Biocon Malaysia received approval from the UK's MHRA for its new fill-finish unit for insulin glargine (Semglee®). This approval enables the company to produce the drug product for the UK market.

Sep 25 2026 08:33:28

Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Biocon's subsidiary received a positive opinion from EMA's CHMP for its Pertuzumab biosimilar (Pebrilzo®). This recommendation for marketing authorization is a key step towards expanding treatment for HER2-positive breast cancer in Europe.

Sep 21 2026 08:28:56

Biocon Ltd - 532523 - Communication Regarding Remittance Of Final Dividend For The FY 2025-26

Biocon has remitted a final dividend of Rs.0.50 per equity share for the financial year 2025-26 to its eligible shareholders. This dividend was approved at the company's 48th Annual General Meeting held on August 06, 2026, with the record date set as July 03, 2026.

Sep 09 2026 14:02:55

Name	Position
Kiran Mazumdar-Shaw	Chairperson
Ravi Rasendra Mazumdar	Non Independent & Non Executive Director

Biocon Similar Stocks

Lupin Ltd.

1936.90

-76.00 (3.78%)

Manipal Health Enterprises Ltd.

684.05

-15.10 (2.16%)

Max Healthcare Institute Ltd.

873.40

-34.60 (3.81%)

Glenmark Pharmaceuticals Ltd.

2192.20

-90.10 (3.95%)

Alkem Laboratories Ltd.

5249.50

-101.00 (1.89%)

Aster DM Quality Care Ltd.

677.15

-3.15 (0.46%)

Fortis Healthcare Ltd.

763.00

-16.10 (2.07%)

Abbott India Ltd.

25580.00

-515.00 (1.97%)

Anthem Biosciences Ltd.

872.55

-14.50 (1.63%)

Gland Pharma Ltd.

3079.10

-71.50 (2.27%)

Biocon FAQs

The Buying Price of Biocon share is 350 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Biocon stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Biocon, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Biocon shares is 118.62. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Biocon shares is 1.73. Useful to assess the stock's value relative to its book value.

To assess Biocon’s valuation compare Sector P/E, P/B which are 42.71 & 3.58 with sector averages, along with growth rates and financial metrics.

The Market Cap of Biocon is 57039.29 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Biocon share price is 447.15 & 337.70. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Biocon belongs to the Healthcare sector.

Open Your Free
Demat Account Now!

AMC for First Year
Auto Square Off Charges

13 Lakh+ Clients
Expert-Backed
Premium Tools